皮肤病治疗市场－全球产业规模、份额、趋势、机会与预测，按应用、药物类别、地区和竞争情况细分，2020-2030 年

2024 年皮肤病治疗市场价值为 218 亿美元，预计到 2030 年将达到 352.5 亿美元，复合年增长率为 8.30%。该市场涵盖影响皮肤、头髮、指甲和黏膜的疾病的诊断和治疗，包括痤疮和湿疹等常见疾病，以及牛皮癣和皮肤癌等严重疾病。由于皮肤病患病率不断上升、人们对皮肤健康的认识不断提高以及生物製剂和个人化医疗技术的进步，对皮肤病治疗的需求正在上升。随着全球人口老化和美学问题的日益突出，市场对医疗和美容皮肤疗法的兴趣日益浓厚。可支配收入的增加，特别是在新兴市场，也使得人们能够更广泛地获得皮肤病治疗。製药创新和数位健康趋势将重塑皮肤病的诊断和治疗方式，推动该行业的持续成长。

关键市场驱动因素

皮肤病盛行率上升

主要市场挑战

通用竞争

主要市场趋势

个人化医疗

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：皮肤病治疗市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依用途分类（脱髮、疱疹、牛皮癣、酒渣鼻、异位性皮肤炎、其他）
  • 依药物类别（抗感染药、皮质类固醇、抗青春痘药、钙调磷酸酶抑制剂、维他命A酸类药物、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美皮肤病治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲皮肤病治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太皮肤病治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲皮肤病治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲皮肤病治疗市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章：全球皮肤病治疗市场：SWOT 分析

第 14 章：竞争格局

• Abbvie Inc. (Allergan PLC)
• Almirall SA
• Amgen Inc.
• Bausch Health Companies Inc.
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company.

第 15 章：策略建议

第16章调查会社について・免责事项

The Dermatological Therapeutics Market was valued at USD 21.80 billion in 2024 and is projected to reach USD 35.25 billion by 2030, growing at a CAGR of 8.30%. This market encompasses the diagnosis and treatment of conditions affecting the skin, hair, nails, and mucous membranes, including common ailments like acne and eczema, as well as serious diseases such as psoriasis and skin cancer. Demand for dermatological treatments is rising due to the growing prevalence of skin disorders, increasing awareness around skin health, and technological advances in biologics and personalized medicine. As the global population ages and aesthetic concerns gain prominence, the market is experiencing heightened interest in both medical and cosmetic skin therapies. Expanding disposable incomes, particularly in emerging markets, are also enabling broader access to dermatological care. Pharmaceutical innovations and digital health trends are poised to reshape how dermatological conditions are diagnosed and managed, driving sustained growth in the sector.

Key Market Drivers

Rising Prevalence of Skin Disorders

The increasing global burden of skin diseases is a primary driver of the Dermatological Therapeutics Market. Skin disorders affect approximately 1.8 billion people worldwide, with estimates suggesting that 30% to 70% of the population experiences some form of dermatological condition at any given time. This widespread prevalence underscores a strong, sustained demand for effective skin treatments. Common conditions such as acne, eczema, psoriasis, atopic dermatitis, rosacea, and various infections are becoming more frequent across all age groups. This expanding patient pool presents a significant opportunity for pharmaceutical companies to develop and market innovative dermatological solutions. Additionally, growing awareness of skin health, driven by social media and increasing focus on aesthetics, further boosts demand for both therapeutic and cosmetic dermatology products. The persistent rise in skin disease incidence makes dermatology one of the most essential and dynamic sectors in healthcare, reinforcing its critical role in global medical infrastructure.

Key Market Challenges

Generic Competition

Generic competition poses a significant challenge to branded pharmaceutical companies operating in the dermatological therapeutics space. Once the patent protection for a drug expires, generic alternatives enter the market, often at significantly lower prices. This price disparity leads to erosion of market share and revenue for original branded products. The transition to generics intensifies pricing pressures, driving down profit margins and fragmenting the market with numerous similar products. Healthcare providers and insurers increasingly favor generics to reduce treatment costs, further impacting demand for branded therapies. For patients and dermatologists, a growing array of generic options can create confusion and complicate prescribing decisions. As the volume of generics increases, innovation may slow due to reduced financial incentives for R&D in new dermatological treatments, challenging companies to maintain competitiveness in a cost-sensitive environment.

Key Market Trends

Personalized Medicine

Personalized medicine is reshaping the landscape of dermatological therapeutics by offering targeted, individualized treatment approaches based on a patient's genetic profile, biomarkers, and disease characteristics. Advances in genomics enable the identification of genetic markers linked to specific skin conditions, such as psoriasis or melanoma, leading to tailored therapeutic interventions. Biomarker analysis allows dermatologists to predict patient responses to certain drugs and monitor disease progression more accurately. The use of biologics and small molecule inhibitors designed to target specific disease pathways has significantly improved outcomes for patients with severe dermatological conditions. Additionally, customized topical formulations-developed in collaboration with compounding pharmacies-address individual needs related to skin type and sensitivities. Personalized medicine also enhances risk stratification and prevention strategies for skin cancers and chronic inflammatory skin diseases. This trend is driving better clinical results, minimizing side effects, and marking a shift toward more effective and proactive dermatological care.

Key Market Players

• Abbvie Inc. (Allergan PLC)
• Almirall SA
• Amgen Inc.
• Bausch Health Companies Inc.
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company

Report Scope:

In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatological Therapeutics Market, By Application:

• Alopecia
• Herpes
• Psoriasis
• Rosacea
• Atopic Dermatitis
• Other

Dermatological Therapeutics Market, By Drug Class:

• Anti-infectives
• Corticosteroids
• Anti-acne
• Calcineurin Inhibitors
• Retinoids
• Other

Dermatological Therapeutics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.

Available Customizations:

Global Dermatological Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Dermatological Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Other)
  • 5.2.2. By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Dermatological Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Drug Class
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermatological Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Drug Class
  • 6.3.2. Canada Dermatological Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Drug Class
  • 6.3.3. Mexico Dermatological Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Drug Class

7. Europe Dermatological Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Drug Class
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermatological Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Drug Class
  • 7.3.2. United Kingdom Dermatological Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Drug Class
  • 7.3.3. Italy Dermatological Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Drug Class
  • 7.3.4. France Dermatological Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Drug Class
  • 7.3.5. Spain Dermatological Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Drug Class

8. Asia-Pacific Dermatological Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Drug Class
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Dermatological Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Drug Class
  • 8.3.2. India Dermatological Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Drug Class
  • 8.3.3. Japan Dermatological Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Drug Class
  • 8.3.4. South Korea Dermatological Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Drug Class
  • 8.3.5. Australia Dermatological Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Drug Class

9. South America Dermatological Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Drug Class
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Dermatological Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Drug Class
  • 9.3.2. Argentina Dermatological Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Drug Class
  • 9.3.3. Colombia Dermatological Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Drug Class

10. Middle East and Africa Dermatological Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Drug Class
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Dermatological Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Drug Class
  • 10.3.2. Saudi Arabia Dermatological Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Drug Class
  • 10.3.3. UAE Dermatological Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Drug Class

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Dermatological Therapeutics Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbvie Inc. (Allergan PLC)
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Almirall SA
• 14.3. Amgen Inc.
• 14.4. Bausch Health Companies Inc.
• 14.5. Galderma SA
• 14.6. GlaxoSmithKline PLC
• 14.7. Johnson & Johnson
• 14.8. Novartis AG
• 14.9. Pfizer Inc.
• 14.10.Bristol-Myers Squibb Company.

15. Strategic Recommendations

16. About Us & Disclaimer